🇺🇸 FDA
Pipeline program

AZD0901

D9800C00001

Phase 3 small_molecule active

Quick answer

AZD0901 for Gastric Cancer is a Phase 3 program (small_molecule) at AstraZeneca with 2 ClinicalTrials.gov record(s).

Program details

Company
AstraZeneca
Indication
Gastric Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials